24 results
6-K
EX-99.2
GMDAQ
Gamida Cell Ltd
9 Dec 20
Report of Foreign Private Issuer
3:37pm
, but are not limited to, those regarding the company’s future financial position and results of operations, the company’s commercialization, anticipated drug pricing, marketing
10-Q
2022 Q1
GMDAQ
Gamida Cell Ltd
12 May 22
Quarterly report
7:42am
, Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce … . At the federal level, the Trump administration used several means to propose or implement drug pricing reform, including through federal budget proposals
10-K
2021 FY
GMDAQ
Gamida Cell Ltd
24 Mar 22
Annual report
7:30am
measures.
In addition, there has been particular and increasing legislative and enforcement interest in the United States with respect to drug pricing practices … drug pricing that seek to implement several of the administration’s proposals. As a result, the FDA concurrently released a final rule and guidance
424B5
zrh36hz4
19 Apr 23
Prospectus supplement for primary offering
6:46am
424B5
j5fitj n6g
20 Apr 23
Prospectus supplement for primary offering
5:27pm
20-F
x9qh vi2ul6k9ucomxne
25 Feb 19
Annual report (foreign)
5:08pm
F-1/A
e142zzd52t1g9
26 Jun 19
Registration statement (foreign) (amended)
12:00am
F-1
yyy8csqt
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
bx2ew38aa8
28 Sep 18
Registration statement (foreign)
4:29pm
F-1/A
0iw5a 09kbs7c
17 Oct 18
Registration statement (foreign) (amended)
6:06am
424B4
52vz1hd3 8h
30 Oct 18
Prospectus supplement with pricing info
8:35am